Modern Medicine Feature Articles

Helping patients better understand glaucomaWhen I was a resident at the SUNY College of Optometry, I was asked a to conduct a few patient question and answer sessions regarding glaucoma. The sessions consisted of me sitting with a small group of patients, family members, or whoever wanted to know more about glaucoma.
Surgical management of melanomaAll surgical management of melanoma is defined by Breslow thickness. For melanoma less than 1 mm in thickness, typically a SLNB is not required. Future imaging devices may better delineate the extent and depth of the tumor in vivo.
New vistas in skin cancer careGenetic profiling is valuable in both diagnosis and prognosis of skin cancer. Hedgehog inhibitors and (superficial radiation therapy) SRT are strong contenders for treating nonmelanoma skin cancer. Advances in targeted therapies and biologics are part of the new wave of melanoma treatments.
New IOL category offers more natural range of visionThere are a number of ways to improve near vision for presbyopes, including multifocal intraocular lenses (IOLs)–traditional or low add–and pseudoaccommodative IOLs. It has been well documented that a small pupil and higher order aberrations, such as spherical aberration (SA) or coma, can increase depth of focus.
Micro-instrumentation reduces trauma in IOL exchangeIncreased procedure volume and patient expectations have made IOL exchange procedures more common. Smaller incisions and the need to reduce trauma require new micro-instrumentation for best outcomes.
Multiple DAAs provide quality care for HCV patientsMultiple oral direct-acting antiviral agents show great promise in treating the vast majority of hepatitis C patients.
DAAs dramatically increase HCV cure rates among veteransThe introduction of direct-acting antiviral agents has transformed hepatitis C care among veterans.
Fluorescent cystoscopy outperforms white light methodA recent study found that compared to white light cystoscopy, fluorescent cystoscopy was linked to a 41% decreased risk of bladder cancer recurrence at less than 3 months.
Chemotherapy may harness immune system in bladder Ca“The immune system may be an under-recognized contributor to the tumor response to chemotherapy,” said researcher Philip H. Abbosh, MD, PhD.
3 steps to success in clinical practiceSo, in optometry, with online refractions, online sales of eyeglasses and contact lenses, and in the face of reduced insurance reimbursements, is true practice autonomy attainable?